Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
3
×
national top stories
clinical trials
new york
new york blog main
new york top stories
san francisco blog main
abbvie
acorda therapeutics
allergan
alnylam pharmaceuticals
ampyra
apokyn
apomorphine
beijing
biotech
brii bio
brii biosciences
bristol-myers squibb
china
clinical data
dalfampridine
deals
duopa
genfit
gilead sciences
glaxosmithkline
gsk
hepatitis b
inbrija
intercept pharmaceuticals
ldl-c
liver
liver disease
madrigal pharmaceuticals
mark pruzanski
mylan
What
disease
3
×
drug
3
×
new
3
×
approved
acorda
adds
alliance
areas
biosciences
bio’s
brii
cope
data
earlier
episodes
fatty
fda
friday
gets
help
hepatitis
horizon
infectious
intercept
known
late
launched
liver
looms
marketed
meant
medications
medicine
medicines
million
mission
nash
nod
nonalcoholic
parkinson’s
Language
Current search:
disease
×
drug
×
" national blog main "
×
new
×
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
